| Debra M Eustace, RNFA | |
|
240 Easton Ave, New Brunswick, NJ 08901 | |
| (732) 565-5410 | |
| (732) 937-9311 |
| Full Name | Debra M Eustace |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Registered Nurse First Assistant |
| Location | 240 Easton Ave, New Brunswick, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306830278 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WR0006X | Registered Nurse - Registered Nurse First Assistant | 26NO07860900 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Debra M Eustace, RNFA 87 Sidney School Rd, Annandale, NJ 08801-3510 Ph: (908) 735-8463 | Debra M Eustace, RNFA 240 Easton Ave, New Brunswick, NJ 08901 Ph: (732) 565-5410 |
News Archive
A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). Published today in Nature Communications, the team's discovery offers a new way to fast-track screening methods used in stem cell research.
"The findings weren't a surprise to us, but we wanted to document the safety of immediate breast reconstruction so that surgeons in other settings can have the same confidence in the approach," Bold said.
By deciphering the near atomic-level structure of the catalytic domain of botulinum toxin type E — one of seven neurotoxins that cause botulism, a disease that paralyzes victims by blocking nerve cells' ability to communicate — scientists at the U.S. Department of Energy's Brookhaven National Laboratory are one step closer to a potential vaccine or treatment.
Genentech, Inc., a member of the Roche Group, announced today that the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 12 to one that use of Avastin® (bevacizumab) in combination with paclitaxel for previously untreated (first-line) advanced HER2-negative breast cancer be removed from Avastin's U.S. label.
In a recent study, scientists have identified seven species of vaginal bacteria that may significantly increase the risk of HIV infection in women.
› Verified 5 days ago
Miss Pamela S Mckinney, CRNFA, CNOR RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Cares Surgery Center, New Brunswick, NJ 08901 Phone: 732-252-8514 | |
Susan Jane Ceci, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Squibb Dr, New Brunswick, NJ 08901 Phone: 732-227-5551 Fax: 732-227-3550 | |
Anna W Ku, Registered Nurse Medicare: Medicare Enrolled Practice Location: 89 French St, New Brunswick, NJ 08901 Phone: 732-235-6230 | |
Lori A. Kalman, APN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 303 George St, Suite 200, New Brunswick, NJ 08901 Phone: 732-236-6800 | |
Loleta C Samuel, NP Registered Nurse Medicare: Medicare Enrolled Practice Location: 195 Little Albany St, New Brunswick, NJ 08901 Phone: 732-235-2465 Fax: 732-235-7355 | |
Susan Anderson, R.N. Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 125 Paterson St, Cab 3100, New Brunswick, NJ 08901 Phone: 718-666-1342 | |
Myung Hee Yoon, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25 Elizabeth St, D, New Brunswick, NJ 08901 Phone: 646-280-6009 |